Bipolar disorder carries a lifetime risk of death by suicide of roughly 6 to 7%, far above the general-population risk. Diagnosis is frequently delayed; a recent systemic review and meta-analysis involving more than 40,000 individuals estimated a median diagnostic delay of 6.7 years. Patients commonly present during depressive episodes, which can obscure a prior history of mania or hypomania. For primary care and behavioral health teams, that gap between onset and accurate recognition is where clinical and documentation risk compounds, making precise episode-type identification, severity staging, and HCC 154 coding among the highest-value actions a care team can take.
AAVBC's Bipolar Disorder Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 and HCC/RAF V28 coding specificity, episode-type and severity staging, diagnostic thresholds and key differentials, comorbidity screening, MEAT documentation standards, medication safety and lithium and valproate monitoring, therapy escalation criteria, and HEDIS quality metrics tie-in. Grounded in current CANMAT, ISBD, and VA/DoD guidance, this guide supports consistent, individualized clinical decision-making, helping care teams document episode specificity accurately, manage medication risk safely, and coordinate psychiatric referral, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of bipolar disorder — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Bipolar disorder carries a lifetime risk of death by suicide of roughly 6 to 7%, far above the general-population risk. Diagnosis is frequently delayed; a recent systemic review and meta-analysis involving more than 40,000 individuals estimated a median diagnostic delay of 6.7 years. Patients commonly present during depressive episodes, which can obscure a prior history of mania or hypomania. For primary care and behavioral health teams, that gap between onset and accurate recognition is where clinical and documentation risk compounds, making precise episode-type identification, severity staging, and HCC 154 coding among the highest-value actions a care team can take.
AAVBC's Bipolar Disorder Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 and HCC/RAF V28 coding specificity, episode-type and severity staging, diagnostic thresholds and key differentials, comorbidity screening, MEAT documentation standards, medication safety and lithium and valproate monitoring, therapy escalation criteria, and HEDIS quality metrics tie-in. Grounded in current CANMAT, ISBD, and VA/DoD guidance, this guide supports consistent, individualized clinical decision-making, helping care teams document episode specificity accurately, manage medication risk safely, and coordinate psychiatric referral, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of bipolar disorder — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
